share_log

Leerink Partners Initiates Coverage On Boundless Bio With Outperform Rating, Announces Price Target of $25

Leerink Partners Initiates Coverage On Boundless Bio With Outperform Rating, Announces Price Target of $25

Leerink Partners以跑赢大盘的评级启动对Boundless Bio的报道,宣布目标股价为25美元
Moomoo 24/7 ·  04/22 15:11

Leerink Partners analyst Michael Cherny initiates coverage on Boundless Bio (NASDAQ:BOLD) with a Outperform rating and announces Price Target of $25.

Leerink Partners分析师迈克尔·切尔尼以跑赢大盘的评级启动了对Boundless Bio(纳斯达克股票代码:BOLD)的报道,并宣布目标股价为25美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发